tiprankstipranks
Trending News
More News >
Purple Biotech (PPBT)
NASDAQ:PPBT
US Market

Purple Biotech (PPBT) Ratios

Compare
992 Followers

Purple Biotech Ratios

PPBT's free cash flow for Q4 2024 was $0.00. For the 2024 fiscal year, PPBT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.71 2.20 4.71 11.41 19.14
Quick Ratio
4.71 2.20 4.71 11.41 19.14
Cash Ratio
2.13 2.02 2.13 2.56 3.63
Solvency Ratio
-2.74 <0.01 -2.74 -3.58 -3.00
Operating Cash Flow Ratio
-2.37 -2.77 -2.37 -3.55 -3.90
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 4.45M$ 5.78M$ 25.73M$ 43.38M$ 55.23M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.01 0.01
Debt-to-Equity Ratio
0.01 0.01 0.01 0.01 0.01
Debt-to-Capital Ratio
0.01 0.01 0.01 0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.16 1.30 1.16 1.08 1.06
Debt Service Coverage Ratio
-163.15 0.00 -163.15 -85.63 -208.87
Interest Coverage Ratio
-179.39 0.00 -179.39 -84.59 206.75
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.02 <0.01 <0.01 <0.01
Net Debt to EBITDA
0.68 0.64 0.68 0.58 0.36
Profitability Margins
Gross Profit Margin
122.09%-0.10%122.09%172.19%76.50%
EBIT Margin
2383.85%-11374.13%2383.85%5545.94%-2864.50%
EBITDA Margin
2361.76%-11350.64%2361.76%5473.75%-2841.00%
Operating Profit Margin
2483.85%11374.13%2483.85%5604.38%1261.20%
Pretax Profit Margin
2391.21%-10202.55%2391.21%5570.63%-2807.40%
Net Profit Margin
2288.46%-10.15%2288.46%5769.69%-1240.50%
Continuous Operations Profit Margin
2391.21%-10202.55%2391.21%5570.63%-2870.10%
Net Income Per EBT
95.70%0.10%95.70%103.57%44.19%
EBT Per EBIT
96.27%-89.70%96.27%99.40%-222.60%
Return on Assets (ROA)
-41.51%-0.04%-38.13%-26.30%-14.80%
Return on Equity (ROE)
-58.61%-0.06%-44.39%-28.48%-15.63%
Return on Capital Employed (ROCE)
-64.04%60.00%-47.52%-27.19%15.63%
Return on Invested Capital (ROIC)
-65.25%59.70%-45.29%-28.08%6.89%
Return on Tangible Assets
-71.48%-0.12%-61.36%-37.14%-19.59%
Earnings Yield
-2.02%-0.98%-0.41%-0.13%-0.09%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 2.00
Payables Turnover
0.09 0.06 0.09 0.16 0.20
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
-1.33 0.42 -1.33 -0.36 1.03
Asset Turnover
-0.02 <0.01 -0.02 >-0.01 0.01
Working Capital Turnover Ratio
-0.03 0.01 -0.03 >-0.01 0.03
Cash Conversion Cycle
-12.49M -6.58K -3.87K -2.33K -1.68K
Days of Sales Outstanding
544.95 0.00 0.00 0.00 182.50
Days of Inventory Outstanding
-6.81M 0.00 0.00 0.00 0.00
Days of Payables Outstanding
5.68M 6.58K 3.87K 2.33K 1.86K
Operating Cycle
-6.81M 0.00 0.00 0.00 182.50
Cash Flow Ratios
Operating Cash Flow Per Share
-0.09 -0.90 -0.09 -0.08 -0.07
Free Cash Flow Per Share
-0.09 -0.90 -0.09 -0.09 -0.07
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.01 1.00 1.01 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
-73.40 -6.64K -73.40 -131.05 -77.51
Capital Expenditure Coverage Ratio
-73.40 -6.64K -73.40 -131.05 -77.51
Operating Cash Flow Coverage Ratio
-32.50 -56.77 -32.50 -20.12 -13.51
Operating Cash Flow to Sales Ratio
18.39 -101.76 18.39 47.10 -12.09
Free Cash Flow Yield
-1.85%-985.69%-0.33%-0.11%-0.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-244.94 -101.70 -244.94 -750.07 -1.06K
Price-to-Sales (P/S) Ratio
-5.61K 10.33 -5.61K -43.28K 13.11K
Price-to-Book (P/B) Ratio
108.74 0.06 108.74 213.62 165.19
Price-to-Free Cash Flow (P/FCF) Ratio
-300.71 -0.10 -300.71 -911.92 -1.07K
Price-to-Operating Cash Flow Ratio
-304.80 -0.10 -304.80 -918.88 -1.08K
Price-to-Earnings Growth (PEG) Ratio
-28.30 1.02 -28.30 -16.88 13.70
Price-to-Fair Value
108.74 0.06 108.74 213.62 165.19
Enterprise Value Multiple
-236.66 0.55 -236.66 -790.04 -461.25
Enterprise Value
297.82M -12.12M 5.09B 13.84B 13.10B
EV to EBITDA
-48.53 0.55 -236.66 -790.04 -461.25
EV to Sales
297.82 -61.88 -5.59K -43.24K 13.10K
EV to Free Cash Flow
-53.26 0.61 -299.85 -911.26 -1.07K
EV to Operating Cash Flow
-53.36 0.61 -303.94 -918.21 -1.08K
Tangible Book Value Per Share
0.14 0.28 0.14 0.25 0.34
Shareholders’ Equity Per Share
0.25 1.55 0.25 0.36 0.46
Tax and Other Ratios
Effective Tax Rate
0.04 0.00 0.04 -0.04 0.56
Revenue Per Share
>-0.01 <0.01 >-0.01 >-0.01 <0.01
Net Income Per Share
-0.11 >-0.01 -0.11 -0.10 -0.07
Tax Burden
1.04 <0.01 0.96 1.04 0.44
Interest Burden
0.93 0.90 1.00 1.00 0.98
Research & Development to Revenue
2.67 87.00 -17.93 -36.96 7.49
SG&A to Revenue
6.08 0.00 -6.55 -18.19 6.07
Stock-Based Compensation to Revenue
1.27 9.58 -2.65 -6.51 2.65
Income Quality
0.95 1.00 0.77 0.85 0.43
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis